- January 17, 2021
- Category: Drugs and Therapeutics, Healthcare and LifeSciences
Global BCG Vaccine Market Size study, by Type (Immune BCG and Therapy BCG) Demographics (Pediatrics (0-18 Years), Adults (19-35 Years)) Application (Hospitals, Clinics, Others) and Regional Forecasts 2020-2027
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million) 1.2.1. BCG Vaccine Market, by Region, 2018-2027 (USD Million) 1.2.2. BCG Vaccine Market, by Type, 2018-2027 (USD Million) 1.2.3. BCG Vaccine Market, by Demographics, 2018-2027 (USD Million) 1.2.4. BCG Vaccine Market, by Application, 2018-2027 (USD Million) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global BCG Vaccine Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global BCG Vaccine Market Dynamics 3.1. BCG Vaccine Market Impact Analysis (2018-2027) 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global BCG Vaccine Market: Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economic 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global BCG Vaccine Market, by Type 5.1. Market Snapshot 5.2. Global BCG Vaccine Market by Type, Performance - Potential Analysis 5.3. Global BCG Vaccine Market Estimates & Forecasts by Type 2017-2027 (USD Million) 5.4. BCG Vaccine Market, Sub Segment Analysis 5.4.1. Immune BCG 5.4.2. Therapy BCG Chapter 6. Global BCG Vaccine Market, by Demographics 6.1. Market Snapshot 6.2. Global BCG Vaccine Market by Demographics, Performance - Potential Analysis 6.3. Global BCG Vaccine Market Estimates & Forecasts by Demographics 2017-2027 (USD Million) 6.4. BCG Vaccine Market, Sub Segment Analysis 6.4.1. Pediatrics (0-18 Years) 6.4.2. Adults (19-35 Years) Chapter 7. Global BCG Vaccine Market, by Application 7.1. Market Snapshot 7.2. Global BCG Vaccine Market by Application, Performance - Potential Analysis 7.3. Global BCG Vaccine Market Estimates & Forecasts by Application 2017-2027 (USD Million) 7.4. BCG Vaccine Market, Sub Segment Analysis 7.4.1. Hospitals 7.4.2. Clinics 7.4.3. Others Chapter 8. Global BCG Vaccine Market, Regional Analysis 8.1. BCG Vaccine Market, Regional Market Snapshot 8.2. North America BCG Vaccine Market 8.2.1. U.S. BCG Vaccine Market 22.214.171.124. Type breakdown estimates & forecasts, 2017-2027 126.96.36.199. Demographics breakdown estimates & forecasts, 2017-2027 188.8.131.52. Application breakdown estimates & forecasts, 2017-2027 8.2.2. Canada BCG Vaccine Market 8.3. Europe BCG Vaccine Market Snapshot 8.3.1. U.K. BCG Vaccine Market 8.3.2. Germany BCG Vaccine Market 8.3.3. France BCG Vaccine Market 8.3.4. Spain BCG Vaccine Market 8.3.5. Italy BCG Vaccine Market 8.3.6. Rest of Europe BCG Vaccine Market 8.4. Asia-Pacific BCG Vaccine Market Snapshot 8.4.1. China BCG Vaccine Market 8.4.2. India BCG Vaccine Market 8.4.3. Japan BCG Vaccine Market 8.4.4. Australia BCG Vaccine Market 8.4.5. South Korea BCG Vaccine Market 8.4.6. Rest of Asia Pacific BCG Vaccine Market 8.5. Latin America BCG Vaccine Market Snapshot 8.5.1. Brazil BCG Vaccine Market 8.5.2. Mexico BCG Vaccine Market 8.6. Rest of The World BCG Vaccine Market Chapter 9. Competitive Intelligence 9.1. Top Market Strategies 9.2. Company Profiles 9.2.1. Merck & Co. Inc. 184.108.40.206. Key Information 220.127.116.11. Overview 18.104.22.168. Financial (Subject to Data Availability) 22.214.171.124. Product Summary 126.96.36.199. Recent Developments 9.2.2. Sanofi Pasteur 9.2.3. Japan BCG Laboratory 9.2.4. China National Biotech Group 9.2.5. Serum Institute of India Pvt. Ltd. 9.2.6. InterVax Ltd. 9.2.7. GreenSignal Bio Pharma Limited (GSBPL) 9.2.8. Statens Serum Institute Chapter 10. Research Process 10.1. Research Process 10.1.1. Data Mining 10.1.2. Analysis 10.1.3. Market Estimation 10.1.4. Validation 10.1.5. Publishing 10.2. Research Attributes 10.3. Research Assumption
Global BCG Vaccine Market is valued approximately at USD 23.25 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.53% over the forecast period 2020-2027. The Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine available to prevent tuberculosis (TB). In countries with a high prevalence of tuberculosis, one dosage is prescribed for babies close to the time of birth. However, in regions where tuberculosis is rare, only children at high risk are usually immunized, while confirmed cases of tuberculosis are directly screened and administered. The vaccine also immunizes people not diagnosed ith tuberculosis and are not vulnerable to drug-resistant tuberculosis. Rising prevalence of tuberculosis, especially in developing and underdeveloped countries, as well as technological advances in the field of vaccine science, are the major factors driving the growth of the BCG vaccine market. Also, as per the Global Tuberculosis Report of 2018, the majority of TB patients (66%) live in one of eight countries: India (27%), China (9%), Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) or South Africa (3 percent). In addition, growing birth rates across the world, especially in China and India, are leading to substantial demand growth. Moreover, cohesive government policies and a global focus on immunization services are pushing the growth of the market upwards. Untapped investment markets in developing regions are projected to have several possibilities for market expansion.
However, side effects of BCG vaccines impede the growth of the market over the forecast period of 2020-2027.
The regional analysis of global BCG Vaccine market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia pacific is the leading/significant region across the world in terms of market share owing to the high prevalence of TB in Asian countries such as India, Pakistan, Bangladesh and others. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rapidly increasing government efforts in form of vaccination drives would create lucrative growth prospects for the BCG Vaccine market across Asia-Pacific region.
Major market player included in this report are:
Merck & Co. Inc.
Japan BCG Laboratory
China National Biotech Group
Serum Institute of India Pvt. Ltd.
GreenSignal Bio Pharma Limited (GSBPL)
Statens Serum Institute
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Pediatrics (0-18 Years)
Adults (19-35 Years)
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global BCG Vaccine Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers